15 november, 2021 Regulatoriskt AcuCort announces that the registration process in the Nordic market is underway for the company’s drug ISICORT®
11 augusti, 2021 Regulatoriskt AcuCort announces that the Board of Directors and the CEO have subscribed for options to purchase shares in the company
26 april, 2021 Regulatoriskt AcuCort progresses into a new phase and strengthens the commercialization team